| Pharmaceutical Information |
| Drug Name |
Perflutren |
| Drug ID |
BADD_D01734 |
| Description |
Perflutren, a diagnostic drug that is intended to be used for contrast enhancement during the indicated echocardiographic procedures, is comprised of lipid-coated microspheres filled with octafluoropropane(OFP) gas. When exposed to ultrasound waves, the microspheres resonate and "echo" strong signals back to the ultrasound machine. The difference in density between the gas-filled bubbles and the blood around them creates an increased level of contrast visible in the resulting ultrasound image. During echocardiography, activated Perflutren enhances images of the inner edges or borders of the heart, producing an improved image that may enable physicians to better diagnose patients. |
| Indications and Usage |
Used as an ultrasound contrast imaging in cardiology and radiology. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB00556
|
| KEGG ID |
D01738
|
| MeSH ID |
C042852
|
| PubChem ID |
6432
|
| TTD Drug ID |
D0G5BK
|
| NDC Product Code |
71124-0016; 11994-011; 11994-017; 63946-0040; 65044-0040 |
| UNII |
CK0N3WH0SR
|
| Synonyms |
perflutren | octafluoropropane | C3F8-gas | perfluoropropane | MRX-115 |
|
| Chemical Information |
| Molecular Formula |
C3F8 |
| CAS Registry Number |
76-19-7 |
| SMILES |
C(C(F)(F)F)(C(F)(F)F)(F)F |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
